James R. Langevin sold ALXN

July 9, 2021 · STOCK Act disclosure

Representative James R. Langevin (Democrat-RI) sold Alexion Pharmaceuticals, Inc., a stock transaction, valued at $15,001 - $50,000. The trade took place on July 9, 2021 and was disclosed on August 14, 2021 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.